Starboard Chief Executive Jeff Smith said that Kenvue, the Tylenol-maker spun out from Johnson & Johnson, should drill down on fixing its underperforming skin health and beauty segment, which he ...
Shares of Kenvue rose more than 5% in premarket trading Monday after The Wall Street Journal reported that activist investor Starboard Value has built a sizable stake in the consumer-products maker ...
Starboard Value reportedly has taken a roughly $1 billion stake in Pfizer, as the activist investor seeks to turn the struggling drugmaker around. According to The Wall Street Journal ...
the Wall Street Journal reported on Sunday. Starboard has approached two former Pfizer executives -- Ian Read and Frank D’Amelio -- who have in turn expressed interest in helping, the WSJ report ...